SCHEMBL26418645

SCHEMBL26418645

CCc1cc(C(C)(C)C)ccc1N1CCC2(CCNCC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.44
CYP2D6 P10635 6/20 0.41
USP2 O75604 4/20 0.41
CYP3A4 P08684 4/20 0.39
TSHR P16473 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
MEN1 O00255 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
KMT2A Q03164 2/20 0.37
HTR1A P08908 2/20 0.37
DRD4 P21917 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
DRD3 P35462 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24123858 0.84 DRD2 (0.48) DRD2CYP2D6USP2CYP3A4TSHR
SCHEMBL25675730 0.83 DRD2 (0.47) DRD2CYP2D6USP2CYP3A4TSHR
SCHEMBL25675717 0.82 DRD2 (0.46) DRD2CYP2D6USP2CYP3A4TSHR
SCHEMBL25675729 0.80 DRD2 (0.64) DRD2CYP2D6USP2CYP3A4TSHR
SCHEMBL25678020 0.76 HTR1A (0.48) DRD2TSHRALDH1A1MAPK1HSD17B10
SCHEMBL25675701 0.76 NPY2R (0.37) DRD2CYP2D6CYP3A4TSHRCYP2C9
SCHEMBL24123997 0.75 CYP2D6 (0.63) DRD2CYP2D6USP2CYP3A4TSHR
SCHEMBL24123588 0.74 HTR1A (0.45) DRD2TSHRHTR1ADRD4HTR2A
SCHEMBL24123837 0.72 HTR3A (0.40) DRD2ALDH1A1MEN1KMT2AHTR1A
SCHEMBL25675623 0.72 HTR1A (0.43) DRD2ALDH1A1HTR1ADRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169919-A1 PYRAZOLO[3,4-D]PYRIMIDINE-3-KETONE DERIVATIVE AS WEE-1 INHIBITOR Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2023-04-26 EP disclosed